osthol has been researched along with Hyperglycemia, Postprandial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chen, NQ; Chen, YC; Hung, LF; Liang, HJ; Liang, YC; Liu, DZ; Suk, FM; Wang, CK | 1 |
Chen, YC; Lee, WH; Liang, YC; Lin, HM; Lin, RJ; Lin, SY | 1 |
2 other study(ies) available for osthol and Hyperglycemia, Postprandial
Article | Year |
---|---|
Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
Topics: 3T3-L1 Cells; Acetyl-CoA Carboxylase; Adenylate Kinase; Adipocytes; Animals; Base Sequence; Cell Differentiation; Coumarins; DNA Primers; Dose-Response Relationship, Drug; Hyperglycemia; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Phosphorylation; PPAR alpha; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Osthole enhances glucose uptake through activation of AMP-activated protein kinase in skeletal muscle cells.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Line; Cnidium; Coumarins; Diabetes Mellitus, Experimental; Enzyme Activation; Glucose; Glucose Transporter Type 4; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; Phosphorylation; Taiwan | 2011 |